Ending the cycle of negative thought rumination is the premise of a depression treatment called metacognitive therapy. New findings suggest that it may be more beneficial in stopping depression relapse than other more commonly used methods. Depression is a huge global health issue. As the leading cause of disability in the United States for those between the ages of 15 and 44 years, it has a significant effect on individuals and society as a whole. With more than 300 million people currently living with depression, finding a long lasting treatment is vital. Unfortunately, relapses are common. Treatments, which include cognitive behavioral therapy (CBT) and medication, can work well in the short term, but many people's symptoms return either within a few months or later on in life. In fact, only about 30% of people with depression have not relapsed 18 months after the end of their treatment. The findings of the new study, which features in Frontiers in Psychology, provide early evidence of the benefits of metacognitive therapy
(Credits: www.medicalnewstoday.com)